Doxorubicin orotate

N/A

Report date: 2026/01/26 13:50:11

Base Information

Drug NameDoxorubicin orotate
Drug Alias NameDOX-O
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionTopoisomerase II inhibitorsVirus DNA polymerase inhibitors
TargetsTopoisomerase IIVirus DNA polymerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSavviPharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSavviPharm Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A